Literature DB >> 708020

High-performance liquid chromatographic assay of chloramphenicol in serum.

J R Koup, B Brodsky, A Lau, T R Beam.   

Abstract

A new method for the analysis of serum chloramphenicol by reversed-phase, high-performance liquid chromatography (HPLC) is described. The method involves a preliminary extraction of 0.1 ml of serum with ethyl acetate containing an internal standard, chromatography with a reversed-phase C18 microparticulate column with an acetonitrile-acetate buffer mobile phase, and detection by measuring UV absorbance at 270 nm. Assay performance was compared with an existing microbiological assay. The HPLC method demonstrated both increased precision and increased sensitivity. The specificity of the HPLC method was also evaluated. The new method presents an alternative approach to the analysis of clinical specimens.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708020      PMCID: PMC352477          DOI: 10.1128/AAC.14.3.439

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  FATAL APLASTIC ANEMIA. AN EPIDEMIOLOGICAL STUDY OF ITS RELATIONSHIP TO THE DRUG CHLORAMPHENICOL.

Authors:  K M SMICK; P K CONDIT; R L PROCTOR; V SUTCHER
Journal:  J Chronic Dis       Date:  1964-10

2.  A CONTROLLED DOUBLE-BLIND STUDY OF THE HEMATOLOGIC TOXICITY OF CHLORAMPHENICOL.

Authors:  J L SCOTT; S M FINEGOLD; G A BELKIN; J S LAWRENCE
Journal:  N Engl J Med       Date:  1965-06-03       Impact factor: 91.245

3.  Chloramphenicol in the newborn infant. A physiologic explanation of its toxicity when given in excessive doses.

Authors:  C F WEISS; A J GLAZKO; J K WESTON
Journal:  N Engl J Med       Date:  1960-04-21       Impact factor: 91.245

4.  An outbreak of neonatal deaths among term infants associated with administration of chloramphenicol.

Authors:  H LISCHNER; S J SELIGMAN; A KRAMMER; A H PARMELEE
Journal:  J Pediatr       Date:  1961-07       Impact factor: 4.406

5.  Fatal circulatory collapse in premature infants receiving chloramphenicol.

Authors:  L E BURNS; J E HODGMAN; A B CASS
Journal:  N Engl J Med       Date:  1959-12-24       Impact factor: 91.245

6.  Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis.

Authors:  C M KUNIN; A J GLAZKO; M FINLAND
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

7.  A cylinder-plate assay for chloromycetin in body fluids and tissue extracts.

Authors:  D G SMITH; C B LANDERS; J FORGACS
Journal:  J Lab Clin Med       Date:  1950-07

8.  Reverse phase high speed liquid chromatography of antibiotics. II. Use of high efficiency small particle columns.

Authors:  E R White; M A Carroll; J E Zarembo
Journal:  J Antibiot (Tokyo)       Date:  1977-10       Impact factor: 2.649

9.  Simultaneous measurement of phenobarbital, phenytoin, primidone, ethosuximide, and carbamazepine in serum by high-pressure liquid chromatography.

Authors:  P M Kabra; B E Stafford; L J Marton
Journal:  Clin Chem       Date:  1977-07       Impact factor: 8.327

10.  CHLORAMPHENICOL IN BLOOD: SIMPLE CHEMICAL ESTIMATIONS IN PATIENTS RECEIVING MULTIPLE ANTIBIOTICS.

Authors:  D W HUGHES; L K DIAMOND
Journal:  Science       Date:  1964-04-17       Impact factor: 47.728

View more
  11 in total

1.  Modification of the colorimetric assay for chloramphenicol in the presence of bilirubin.

Authors:  E O Mason; S L Kaplan; C J Baker; D A Ritter
Journal:  Antimicrob Agents Chemother       Date:  1979-04       Impact factor: 5.191

2.  Relationship between serum and saliva chloramphenicol concentrations.

Authors:  J R Koup; A H Lau; B Brodsky; R L Slaughter
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

Review 3.  Chloramphenicol in the 1980s.

Authors:  I Shalit; M I Marks
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

4.  Evaluation of new blood culture processing systems.

Authors:  J A Moody; C E Fasching; C J Shanholtzer; D N Gerding; L R Peterson
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

5.  Chloramphenicol bioassay.

Authors:  R M Bannatyne; R Cheung
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

Review 6.  Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.

Authors:  P J Ambrose
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

7.  Comparison of cefamandole, cephalothin, ampicillin, and chloramphenicol in experimental Escherichia coli meningitis.

Authors:  T R Beam; J C Allen
Journal:  Antimicrob Agents Chemother       Date:  1980-01       Impact factor: 5.191

8.  Chloramphenicol pharmacokinetics in hospitalized patients.

Authors:  J R Koup; A H Lau; B Brodsky; R L Slaughter
Journal:  Antimicrob Agents Chemother       Date:  1979-05       Impact factor: 5.191

9.  High-pressure liquid chromatographic assay of chloramphenicol in biological fluids.

Authors:  R H Sample; M R Glick; M B Kleiman; J W Smith; T O Oei
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

Review 10.  Serum level monitoring of antibacterial drugs. A review.

Authors:  M Wenk; S Vozeh; F Follath
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.